Publication & Citation Trends
Publications
0 total
Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy: Exploratory Insights From the ODYSSEY-HCM Trial.
Cited by 8
Semantic Scholar
EFFECT OF AFICAMTEN TREATMENT FOR UP TO 72 WEEKS ON CARDIAC STRUCTURE AND FUNCTION IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: THE SEQUOIAHCM AND FOREST-HCM CMR SUB-STUDIES
Cited by 0
Semantic Scholar
1-036 RIDGETM-1: a phase 1b interventional study to evaluate safety and efficacy of TN-401, an adeno-associated virus serotype 9 (AAV9) investigational gene therapy, in adults withPKP2-associated arrhythmogenic right ventricular cardiomyopathy (ARVC)
Cited by 0
Semantic Scholar
Aficamten Treatment for Symptomatic Obstructive Hypertrophic Cardiomyopathy: 48-Week Results From FOREST-HCM.
Cited by 12
Semantic Scholar
Abstract 4358220: Patient-derived iPSC-cardiomyocytes harbouring deep intronic MYBPC3 variants show features consistent with hypertrophic cardiomyopathy
Cited by 0
Semantic Scholar
SAFETY AND OUTCOMES OF CONCOMITANT AFICAMTEN AND DISOPYRAMIDE USE AND WITHDRAWAL IN PATIENTS WITH OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY: AN ANALYSIS OF REDWOOD-HCM COHORT 3, SEQUOIA-HCM, AND FOREST-HCM TRIALS
Cited by 0
Semantic Scholar
Abstract 4365842: Chronic Aficamten Treatment Results in Sustained Favorable Cardiac Remodeling in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights From the FOREST-HCM Trial
Cited by 0
Semantic Scholar
Abstract 4368742: Long-term Impact of Aficamten on Patient-Reported Outcome Measures in Obstructive Hypertrophic Cardiomyopathy: Results From FOREST-HCM
Cited by 0
Semantic Scholar
Research Topics
Cardiomyopathy and Myosin Studies
(577)
Cardiovascular Effects of Exercise
(278)
Cardiovascular Function and Risk Factors
(180)
Viral Infections and Immunology Research
(119)
Cardiac pacing and defibrillation studies
(91)
Affiliations
Statens Serum Institut
Kagoshima University
University of Pisa
American College of Cardiology
Northwestern University